Neuromodulators demonstrate efficacy in functional GI presentations.
Emergency physicians documented durable relief of refractory nausea, cyclic vomiting, and chronic abdominal pain using dopamine-antagonist medications, including droperidol and haloperidol, in patients unresponsive to conventional antiemetics. A November 2019 review in Emergency Medicine News summarized the proposed mechanism: dopamine blockade at the chemoreceptor trigger zone, the brainstem region governing nausea, together with altered gut motility and reduced central amplification of visceral signals.
The clinical implication is structural: the gut and the brain operate as a single circuit, and intervening on the neural side of that circuit produces measurable gastrointestinal effects.




